FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4328132512> ?p ?o ?g. }

• W4328132512 abstract "Summary To identify novel drivers of malignancy in pancreatic ductal adenocarcinoma (PDAC), we employed regulatory network analysis, which calculates the activity of transcription factors and other regulatory proteins based on the integrated expression of their positive and negative target genes. We generated a regulatory network for the malignant epithelial cells of human PDAC using gene expression data from a set of 197 laser capture microdissected human PDAC samples and 45 low-grade precursors, for which we had matched histopathological, clinical, and epidemiological annotation. We then identified the most highly activated and repressed regulatory proteins (e.g. master regulators or MRs) associated with four malignancy phenotypes: precursors vs. PDAC (initiation), low-grade vs. high grade histopathology (progression), survival post resection, and association with KRAS activity. Integrating across these phenotypes, the top MR of PDAC malignancy was found to be BMAL2, a member of the PAS family of bHLH transcription factors. Although the canonical function of BMAL2 is linked to the circadian rhythm protein CLOCK, annotation of BMAL2 target genes highlighted a potential role in hypoxia response. We previously demonstrated that PDAC is hypovascularized and hypoperfused, and here show that PDAC from the genetically engineered KPC model exists in a state of extreme hypoxia, with a partial oxygen pressure of <1mmHg. Given the close homology of BMAL2 to HIF1β (ARNT) and its potential to heterodimerize with HIF1A and HIF2A, we investigated whether BMAL2 plays a role in the hypoxic response of PDAC. Indeed, BMAL2 controlled numerous hypoxia response genes and could be inhibited following treatment with multiple RAF, MEK, and ERK inhibitors, validating its association with RAS activity. Knockout of BMAL2 in four human PDAC cell lines led to defects in growth and invasion in the setting of hypoxia. Strikingly, BMAL2 null cells failed to induce glycolysis upon exposure to severe hypoxia and this was associated with a loss of expression of the glycolytic enzyme LDHA. Moreover, HIF1A was no longer stabilized under hypoxia in BMAL2 knockout cells. By contrast, HIF2A was hyper-stabilized under hypoxia, indicating a dysregulation of hypoxia metabolism in response to BMAL2 loss. We conclude that BMAL2 is a master regulator of hypoxic metabolism in PDAC, serving as a molecular switch between the disparate metabolic roles of HIF1A- and HIF2A-dependent hypoxia responses. Statement of Significance There is a surprising disconnect between the genomic alterations present in pancreatic ductal adenocarcinoma and key phenotypes of malignancy, suggesting that non-genetic factors must play a role. Here we analyze changes in regulatory state – calculated from network analysis of RNA expression data – to identify transcription factors and other regulatory proteins whose activities drive pancreatic cancer malignancy. We identified the top candidate, BMAL2, as a novel, KRAS-responsive regulator of hypoxic response in pancreatic cancer, serving as a switch between HIF1A and HIF2A expression. These data help explain how KRAS coordinates cell regulatory state to enable tumor cells to survive extreme hypoxia, and highlight the ability of regulatory network analysis to identify overlooked, key drivers of biological phenotypes." @default.
• W4328132512 created "2023-03-22" @default.
• W4328132512 creator A5006425988 @default.
• W4328132512 creator A5011216679 @default.
• W4328132512 creator A5013689216 @default.
• W4328132512 creator A5015596592 @default.
• W4328132512 creator A5018554532 @default.
• W4328132512 creator A5021028061 @default.
• W4328132512 creator A5028724731 @default.
• W4328132512 creator A5032644187 @default.
• W4328132512 creator A5032670177 @default.
• W4328132512 creator A5039092114 @default.
• W4328132512 creator A5039124220 @default.
• W4328132512 creator A5040927017 @default.
• W4328132512 creator A5042348033 @default.
• W4328132512 creator A5043154527 @default.
• W4328132512 creator A5046245448 @default.
• W4328132512 creator A5060009253 @default.
• W4328132512 creator A5060512446 @default.
• W4328132512 creator A5063496433 @default.
• W4328132512 creator A5064382875 @default.
• W4328132512 creator A5068898743 @default.
• W4328132512 creator A5069911791 @default.
• W4328132512 creator A5078241450 @default.
• W4328132512 creator A5082761210 @default.
• W4328132512 creator A5083809253 @default.
• W4328132512 creator A5084696219 @default.
• W4328132512 creator A5085494535 @default.
• W4328132512 creator A5085740229 @default.
• W4328132512 creator A5087518703 @default.
• W4328132512 date "2023-03-21" @default.
• W4328132512 modified "2023-10-02" @default.
• W4328132512 title "Ras-dependent activation of BMAL2 regulates hypoxic metabolism in pancreatic cancer" @default.
• W4328132512 cites W1497915798 @default.
• W4328132512 cites W1533942137 @default.
• W4328132512 cites W1972632508 @default.
• W4328132512 cites W1996667997 @default.
• W4328132512 cites W2012435615 @default.
• W4328132512 cites W2023300506 @default.
• W4328132512 cites W2029473942 @default.
• W4328132512 cites W2039262188 @default.
• W4328132512 cites W2041485960 @default.
• W4328132512 cites W2047940964 @default.
• W4328132512 cites W2068787504 @default.
• W4328132512 cites W2069269337 @default.
• W4328132512 cites W2069663698 @default.
• W4328132512 cites W2071268727 @default.
• W4328132512 cites W2073098012 @default.
• W4328132512 cites W2077128508 @default.
• W4328132512 cites W2091854488 @default.
• W4328132512 cites W2099001714 @default.
• W4328132512 cites W2100029555 @default.
• W4328132512 cites W2105031411 @default.
• W4328132512 cites W2107441200 @default.
• W4328132512 cites W2110265246 @default.
• W4328132512 cites W2130410032 @default.
• W4328132512 cites W2138485734 @default.
• W4328132512 cites W2142094922 @default.
• W4328132512 cites W2146512944 @default.
• W4328132512 cites W2154790710 @default.
• W4328132512 cites W2159675211 @default.
• W4328132512 cites W2161409973 @default.
• W4328132512 cites W2166082118 @default.
• W4328132512 cites W2170291081 @default.
• W4328132512 cites W2179438025 @default.
• W4328132512 cites W2285093314 @default.
• W4328132512 cites W2336715782 @default.
• W4328132512 cites W2340408307 @default.
• W4328132512 cites W2342019990 @default.
• W4328132512 cites W2401459239 @default.
• W4328132512 cites W2431396139 @default.
• W4328132512 cites W2470222015 @default.
• W4328132512 cites W2472255748 @default.
• W4328132512 cites W2566656214 @default.
• W4328132512 cites W2576896693 @default.
• W4328132512 cites W2584230628 @default.
• W4328132512 cites W2604454943 @default.
• W4328132512 cites W2742000848 @default.
• W4328132512 cites W2748710555 @default.
• W4328132512 cites W2785043177 @default.
• W4328132512 cites W2796153844 @default.
• W4328132512 cites W2808357284 @default.
• W4328132512 cites W2889433609 @default.
• W4328132512 cites W2891678790 @default.
• W4328132512 cites W2899227358 @default.
• W4328132512 cites W2900310474 @default.
• W4328132512 cites W2901608487 @default.
• W4328132512 cites W2904107848 @default.
• W4328132512 cites W2910033560 @default.
• W4328132512 cites W2920097475 @default.
• W4328132512 cites W2944727022 @default.
• W4328132512 cites W2993292777 @default.
• W4328132512 cites W2999027176 @default.
• W4328132512 cites W2999646041 @default.
• W4328132512 cites W3015020891 @default.
• W4328132512 cites W3022015399 @default.
• W4328132512 cites W3044045036 @default.
• W4328132512 cites W3080328852 @default.
• W4328132512 cites W3204042629 @default.
• W4328132512 doi "https://doi.org/10.1101/2023.03.19.533333" @default.

• next